Purpose of Review A multisystem inflammatory condition occurring in children and
adolescents with COVID-19 has become increasingly recognized and widely studied …

Abstract Purpose of Review We provide the readers with a review of cardiac complications
in children with multi-system inflammatory syndrome in children (MIS-C) and its short-term …

Multisystem inflammatory syndrome in children (MIS‐C) is a rare, but severe complication of
coronavirus disease 2019 (COVID‐19). It develops approximately 4 weeks after severe …

Although children are likely to have a milder COVID-19 course compared with adults, MIS-C
as a postinfectious and life-threatening complication was reported in the pediatric age. After …

Background In April 2020, case series emerged from the UK, Italy, and later from the US
describing children admitted to the hospital for persistent fever, diffuse inflammation, and …

Multisystem Inflammatory Syndrome in Children (MIS-C) is defined as a clinically serious
condition requiring hospitalization with fever, multi-system organ disfunction, inflammatory …

MIS-C is a systemic inflammation disorder with poorly characterised immunopathological
mechanisms. We compared changes in the systemic immune response in children with MIS …

The rapid development and deployment of effective vaccines against SARS-CoV-2 infection
has been a historic achievement. Children, while not the primary age group affected by …

Since the sudden emergence of multisystem inflammatory disease in children (MIS-C) in
April 2020 as a novel and severe presentation of coronavirus disease 2019 (Covid-19) …

Background Despite similar rates of infection, adults and children have markedly different
morbidity and mortality related to severe acute respiratory syndrome coronavirus-2 (SARS …